InnoPharmax Market Cap

InnoPharmax has a market cap or net worth of 1.69 billion as of April 25, 2025. Its market cap has increased by 8.08% in one year.

Market Cap

1.69B

Enterprise Value

1.42B

Revenue

32.30M

Ranking

n/a

PE Ratio

n/a

Stock Price

15.45

Market Cap Chart

Since September 13, 2012, InnoPharmax's market cap has increased from 1.54B to 1.69B, an increase of 9.55%. That is a compound annual growth rate of 0.73%.

Market Cap History

Date	Market Cap	% Change
Apr 25, 2025	1.69B	-3.39%
Dec 31, 2024	1.75B	5.76%
Dec 29, 2023	1.65B	62.70%
Dec 30, 2022	1.02B	-32.67%
Dec 30, 2021	1.51B	15.28%
Dec 31, 2020	1.31B	52.08%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	166.35B
Caliway Biopharmaceuticals	94.62B
Bora Pharmaceuticals Co., LTD.	70.34B
Lotus Pharmaceutical	56.92B
Oneness Biotech	29.26B
Polaris Group	28.85B
Lumosa Therapeutics	26.18B
Pegavision	25.55B

Market Cap Rankings